Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
121 participants
OBSERVATIONAL
2023-03-01
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Predictive Factors of Success of Hysteroscopic Endometrial Ablation/Resection
NCT05483348
Implementation of Hysteroscopy in Flanders and the Netherlands
NCT02853695
NOVasure EXpierences (NOVEX)
NCT06397898
Investigation of the Incidence of Complications After Vaginal and Abdominal Hysterectomy
NCT00181311
NovaSure Study: Endometrial Ablation in Women With Heavy Menstrual Bleeding
NCT05856838
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In addition, multiple variables were analyzed in predicting the occurrence of incomplete endometrial ablation, including age, BMI, cavum length, cavum width, ablation time, ablation power, nulliparity, sterilization in history, section caesarea in history, position of the uterus (AVF/RVF), presence of myomas, the presence of adenomyosis and surgery under local anesthesia, generally without sterilization or generally in combination with sterilization. Information was collected from EPD and the MIRA and MIRA2 databases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Complete Novasure endometrial ablation
After treatment with novasure, the hysteroscopy showed no remains of endometrium, , so a complete novasure endomentrial ablation
hysteroscopy
uterine hysteroscopy right after Novasure endometrial ablation
Incomplete Novasure endometrial ablation
After treatment with novasure, the hysteroscopy showed remains of endometrium, so an incomplete novasure endomentrial ablation
hysteroscopy
uterine hysteroscopy right after Novasure endometrial ablation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hysteroscopy
uterine hysteroscopy right after Novasure endometrial ablation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women had to suffer from heavy menstrual bleeding
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maxima Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Danique Roelen
Medical student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marlies M.Y. Bongers, PhD, MD
Role: PRINCIPAL_INVESTIGATOR
Maxima Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Máxima MC
Veldhoven, North Brabant, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Incomplete Novasure ablation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.